Related Experiment Video
Updated: Jul 30, 2026

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
The computer-assisted morphological classification of acute leukemia. I. Preliminary results
Automated microscopy of leukemic lymphoblasts in childhood acute lymphoblastic leukemia (ALL) can predict treatment response. Specific cell morphology metrics identify patients likely to achieve long-term remission or experience poor outcomes.
Area of Science:
- Pediatric Oncology
- Hematology
- Computational Pathology
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Accurate prediction of treatment response is crucial for optimizing pediatric ALL management.
- Morphological assessment of bone marrow aspirates is a standard diagnostic procedure.
Purpose of the Study:
- To evaluate the utility of computer-assisted automated microscopy for assessing leukemic lymphoblast morphology in pediatric ALL.
- To determine if specific morphological features can predict treatment response and long-term remission in children with ALL.
Main Methods:
- Morphological analysis of leukemic lymphoblasts from bone marrow aspirates of 40 children with ALL.
- Utilized a computer-assisted automated microscope for cell evaluation.
- Developed a predictive statistic based on macrolymphoblast count and non-cytoplasmic cell percentage.
Main Results:
- A novel statistic combining macrolymphoblast count and percentage of cells lacking cytoplasm effectively predicted treatment response.
- This statistic identified patients with a high likelihood of long-term remission.
- The statistic also distinguished a subgroup of patients with a relatively poor response to standard therapy.
Conclusions:
- Computer-assisted automated analysis of lymphoblast morphology offers a valuable tool for predicting treatment outcomes in pediatric ALL.
- Morphological parameters can aid in stratifying patients for risk-adapted therapy.
- This approach may improve the personalization of ALL treatment strategies.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
09:11Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
Published on: January 27, 2023